Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/ebm/ValueSet/research-study-classifier | Version: 1.0.0-ballot3 | |||
| Standards status: Trial-use Active as of 2026-01-13 | Maturity Level: 1 | Computable Name: ResearchStudyClassifier | ||
| Other Identifiers: OID:2.16.840.1.113883.4.642.40.44.48.11 | ||||
Codes for use with the ResearchStudy.classifier element.
References
Expansion performed internally based on codesystem ResearchStudy Classifier Code System v1.0.0-ballot3 (CodeSystem)
This value set contains 26 concepts
| System | Code | Display (en) | Definition | JSON | XML |
https://fevir.net/resources/CodeSystem/419455 | fda-regulated-drug | FDA regulated drug | A medication regulated by the U.S. Food and Drug Administration. | ||
https://fevir.net/resources/CodeSystem/419455 | fda-regulated-device | FDA regulated device | A medical device regulated by the U.S. Food and Drug Administration. | ||
https://fevir.net/resources/CodeSystem/419455 | irb-exempt | IRB-exempt | Human subjects research that is excempt from oversight and monitoring by an institutional review board (IRB). | ||
https://fevir.net/resources/CodeSystem/419455 | mpg-paragraph-23b | MPG Paragraph 23b | Research regulated by a specific German legal requirement (Medizinproduktegesetz MPG Paragraph 23b). | ||
https://fevir.net/resources/CodeSystem/419455 | includes-females | Includes female subjects | Includes female subjects | ||
https://fevir.net/resources/CodeSystem/419455 | does-not-include-females | Does not include female subjects | Does not include female subjects | ||
https://fevir.net/resources/CodeSystem/419455 | includes-males | Includes male subjects | Includes male subjects | ||
https://fevir.net/resources/CodeSystem/419455 | does-not-include-males | Does not include male subjects | Does not include male subjects | ||
https://fevir.net/resources/CodeSystem/419455 | includes-vulnerable-population | Includes vulnerable populations | Includes vulnerable populations | ||
https://fevir.net/resources/CodeSystem/419455 | does-not-include-vulnerable-population | Does not include vulnerable populations | Does not include vulnerable populations | ||
https://fevir.net/resources/CodeSystem/419455 | includes-healthy-volunteers | Includes healthy volunteers | Includes healthy volunteers | ||
https://fevir.net/resources/CodeSystem/419455 | does-not-include-healthy-volunteers | Does not include healthy volunteers | Does not include healthy volunteers | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-in-utero | Includes ages in utero | Includes subjects who are not yet born | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-0-17 | Includes ages 0-17 years | Includes subjects between birth and 17 years of age (not yet 18 years old) | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-18-64 | Includes ages 18-64 years | Includes subjects between 18 and 64 years of age (not yet 65 years old) | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-65-and-older | Includes ages 65 and older | Includes subjects aged 65 years and older | ||
https://fevir.net/resources/CodeSystem/419455 | includes-preterm-newborns | Includes preterm newborns | Includes subjects who are preterm newborns (up to gestational age < 37 weeks) | ||
https://fevir.net/resources/CodeSystem/419455 | includes-neonates | Includes neonates | Includes subjects between 0 and 27 days of age | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-28-day-23-month | Includes ages 28 days to 23 months | Includes subjects between 28 days and 23 months of age | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-2-5 | Includes ages 2-5 years | Includes subjects between 2 and 5 years of age (not yet 6 years old) | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-6-11 | Includes ages 6-11 years | Includes subjects between 6 and 11 years of age (not yet 12 years old) | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-12-17 | Includes ages 12-17 years | Includes subjects between 12 and 17 years of age (not yet 18 years old) | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-65-84 | Includes ages 65-84 years | Includes subjects between 65 and 84 years of age (not yet 85 years old) | ||
https://fevir.net/resources/CodeSystem/419455 | includes-ages-85-and-older | Includes ages 85 and older | Includes subjects aged 85 years and older | ||
https://fevir.net/resources/CodeSystem/419455 | includes-patients | Includes patients | Includes patients | ||
https://fevir.net/resources/CodeSystem/419455 | does-not-include-patients | Does not include patients | Does not include patients |
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-ballot3.
Generated
2026-01-13
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change